Published 3 years ago

NIH director believes widespread coronavirus vaccine boosters will be recommended despite FDA opinion

Summary by Fox News

Dr. Francis Collins, director of the National Institutes of Health, maintained his support for people under age 65 who have been vaccinated against coronavirus to get a booster shot even after the FDA would not approve it.

0 Articles

All

Left

Center

Right

Times of India

Health official: Booster use may be expanded

Rest of World News: WASHINGTON: The National Institutes of Health director says a government advisory panel's decision to limit Pfizer Covid-19 booster shots to Americans.

3 years ago·India

Read Full Article

Yahoo News

NIH director on coronavirus boosters: 'Would be surprised' if not recommended

Dr. Francis Collins weighs in on the implementation of a third vaccine dose under the Biden administration.

3 years ago·Los Angeles, United States

Read Full Article

News18 India

Covid Vaccine Booster Use May Be Expanded, Say US Health Officials

Dr. Anthony Fauci, who is President Joe Bidens chief medical adviser, on Sunday praised the advisory boards plan for covering a good chunk of Americans.

3 years ago·India

Read Full Article

Associated Press News

The Latest: Health official: Booster use may be expanded

WASHINGTON -- The National Institutes of Health director says a government advisory panel’s decision to limit Pfizer COVID-19 booster shots to Americans 65 and older as well as those at high risk of severe disease is a preliminary step and…

3 years ago·United States

Read Full Article

CBS News

Francis Collins, NIH chief, expects FDA to expand COVID-19 booster recommendation in "coming weeks"

A FDA panel on Friday declined to recommend booster shots for the general public.

3 years ago

Read Full Article

The Hill

NIH director expects booster shots to be expanded, despite FDA advisers' recommendation

Francis Collins, director of the National Institutes of Health (NIH), said on Sunday that it would "surprise" him if COVID-19 booster shot aren't expanded, despite a recommendation from a Food and Drug Administration (FDA) panel adv

3 years ago·Washington, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.